Rubedo Life Sciences
About Rubedo Life Sciences
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Series A T: - FT: Series A |
A: 40000000 MR: - FA: $40M FAN: 40000000 |
D: 2024-04-22 FD: 2024-04-22 |
11 investors |
| 2 |
RT: Grant T: - FT: Grant |
A: 1450000 MR: - FA: 1.45M FAN: 1450000 |
D: 2023-02-06 FD: 2023-02-06 |
1 investors |
Growth Metrics
Team & Leadership
Frederick Beddingfield
Chief Executive Officer
Marco Quarta
Co-Founder and Chief Scientific Officer
Alex Laslavic
Chief Technology Officer
Julianne Averill
Chief Financial Officer
Ali Siam
Chief Business Officer
Mary Spellman
Chief Medical Officer
Recent News
Rubedo Life Sciences Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- rubedolife.com
- Industries
- Biotechnology / Life Sciences
- Company Size
- ~480 employees (est.)
- Locations
-
Milan, Italy
Silicon Valley, USA
Sunnyvale, CA, USA
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro